Bayer (Global Rights To Hormonal Contraceptive) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Bayer (Global Rights To Hormonal Contraceptive) General Information

Description

Global rights to hormonal contraceptive based in Switzerland.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Zurich
  • Switzerland
Primary Industry
Pharmaceuticals
Corporate Office
  • Zurich
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bayer (Global Rights To Hormonal Contraceptive) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bayer (Global Rights To Hormonal Contraceptive)‘s full profile, request access.

Request a free trial

Bayer (Global Rights To Hormonal Contraceptive) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bayer (Global Rights To Hormonal Contraceptive)‘s full profile, request access.

Request a free trial

Bayer (Global Rights To Hormonal Contraceptive) FAQs

  • Where is Bayer (Global Rights To Hormonal Contraceptive) headquartered?

    Bayer (Global Rights To Hormonal Contraceptive) is headquartered in Zurich, Switzerland.

  • What industry is Bayer (Global Rights To Hormonal Contraceptive) in?

    Bayer (Global Rights To Hormonal Contraceptive)’s primary industry is Pharmaceuticals.

  • Is Bayer (Global Rights To Hormonal Contraceptive) a private or public company?

    Bayer (Global Rights To Hormonal Contraceptive) is a Private company.

  • What is Bayer (Global Rights To Hormonal Contraceptive)’s current revenue?

    The current revenue for Bayer (Global Rights To Hormonal Contraceptive) is .

  • Who are Bayer (Global Rights To Hormonal Contraceptive)’s investors?

    Bayer has invested in Bayer (Global Rights To Hormonal Contraceptive).

  • When was Bayer (Global Rights To Hormonal Contraceptive) acquired?

    Bayer (Global Rights To Hormonal Contraceptive) was acquired on 06-Aug-2018.

  • Who acquired Bayer (Global Rights To Hormonal Contraceptive)?

    Bayer (Global Rights To Hormonal Contraceptive) was acquired by Luye Pharma Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process